Psychiatric disorders' influence on relapse during complex detox
Official title: Psychiatric Disorders in Addiction - Interest of Screening and Influence on Relapse
Run by University Hospital, Strasbourg, France · NCT07023419 · Data updated 2026-11-12
This project will test whether screening for psychiatric diagnoses can help predict and reduce relapse risk in people aged 16 and older hospitalized for complex detox at CHU de Strasbourg.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 16 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg) |
| Status | Recruiting |
| Started | December 16, 2024 |
| Main results expected | October 16, 2026 |
| Study ends | October 16, 2026 |
| Registry record updated | June 22, 2025 |
| Trial ID | NCT07023419 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
People aged 16 or older who were hospitalized in the complex withdrawal unit at the CHU de Strasbourg during the study period and agree to participate.
✕Probably not a fit
Patients under 16, those not hospitalized in this specific unit or timeframe, or whose relapses are driven primarily by non-psychiatric factors may not gain direct benefit from the findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational study of patients admitted to the complex withdrawal unit at the CHU de Strasbourg between January 1 and November 1, 2024. Investigators will collect psychiatric diagnoses and responses to screening questionnaires and record relapses that occur during hospitalization. They will analyze which psychiatric diagnoses are associated with higher relapse risk and whether routine screening questionnaires improve diagnostic reliability. The findings will be used to suggest ways to adapt care and reduce in-hospital relapse rates.
Why it matters
Potential benefit: If successful, the results could help tailor care to patients' psychiatric risk profiles and reduce in-hospital relapses.
How similar studies have gone: Previous research has linked psychiatric diagnoses to higher relapse risk, but which specific diagnoses matter and the added value of screening questionnaires remain uncertain.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subject aged ≥16 * Having been hospitalized in the complex withdrawal unit of the Strasbourg psychiatric clinic during the period from January 1, 2024 to November 1, 2024 Exclusion Criteria: * Refusal to participate in the study
Where it's running
-
Service d'Addictologie - CHU de Strasbourg - France
Strasbourg, France Recruiting
Study contacts
- Study coordinator: Amaury DURPOIX, MD
- Email: amaury.durpoix@chru-strasbourg.fr
- Phone: 33 6 77 90 62 28
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
French validation of the Recovery Assessment Scale for mental health
This study tests whether a French version of the Recovery Assessment Scale works well for adults receiving psychiatric care.
-
Lemborexant for insomnia in people with psychiatric conditions
We will try lemborexant for 8 weeks in adults with psychiatric disorders who have insomnia to see if it helps them sleep better and is safe.
-
Virtual reality schema therapy exercises with parent and child modes
This study tests whether virtual-reality dialogue exercises using parent and child avatars are feasible and helpful for adults (18–65) with psychiatric symptoms linked to early-life experiences.
-
Effectiveness of the SKILLS Program for Mental Health Care
This study tests whether the SKILLS psychotherapy program can help adults with a psychiatric disorder improve their mental health.
-
Gaze-Contingent Music Therapy to Help Kids with Anxiety
This study is testing if adding a special music therapy to regular talk therapy can help kids and teens with anxiety feel better.
-
Treatment for individuals involved with the criminal justice system to assess and prevent suicide risk
This study is testing a new way to help people in the criminal justice system who are at risk of suicide by using health and jail records to provide better support and treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.